Algorithm-guided, personalized care for chronic low back pain did not reduce disability compared with usual care among older veterans.

A Phase 3 study in the U.S. is planned to start in early 2026 to support a submission for FDA approval. MUNICH, Oct. 1, 2025 /CNW/ -- Vertanical today announced publication of results from two Phase 3 ...

Touted as an alternative to opioid painkillers since its 2017 approvals in the U.S. and Europe, the devicemaker’s Intellis spinal cord stimulator demonstrated it could cut reported back pain by at ...

A clinical trial on the VIA Disc NP treatment for discogenic back pain has shown impressive results, significantly reducing pain and improving back function. The non-surgical, minimally invasive ...

One evening in July of 2020, a woman named Kathryn went to the hospital in excruciating pain. A 32-year-old psychology grad student in Michigan, Kathryn lived with endometriosis, an agonizing ...

The algorithm also addresses pharmacologic approaches for debilitating and nondebilitating breast pain. 15-22 A short course of a scheduled oral nonsteroidal anti-inflammatory medication can improve ...

A large proportion of patients with cancer suffer from breakthrough cancer pain (BTcP). Several unmet clinical needs concerning BTcP treatment, such as optimal opioid dosages, are being investigated.

Roche has introduced its Chest Pain Triage algorithm, designed to rapidly identify acute coronary syndrome (ACS). This algorithm, part of the company’s cloud-based platform navify Algorithm Suite, ...

VER-01 significantly reduced pain intensity in chronic low back pain compared with placebo, with effects sustained during 12 months of treatment. VER-01 was generally well tolerated, with no signs of ...